from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1435c/-

LFCtreatmentdescriptionclass of inhibitor

0.473

Amikacinug/mL Amikacintranslation

0.758

Cap5-10ug/mL Capreomycintranslation

0.568

Rox10-50 ug/mL Roxithromycintranslation

-0.628

SM2-5 ug/mL Streptomycintranslation

-0.799

Tet5-10 ug/mL Tetracyclinetranslation

-0.037

Rif0.2-5ug/mL Rifampicintranscription

-1.042

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.116

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.417

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.251

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.919

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.080

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.438

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.970

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.039

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.086

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.353

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.687

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.511

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.158

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.449

KCN5-20 ug/mL Potassium cyaniderespiration

0.530

NaN30.2-2 mM Sodium aziderespiration

-0.486

Nigericin50 uM Nigericinrespiration

0.218

TRC10-150 ug/mL Triclosanrespiration

-0.486

TRZ10-25 ug/mL Thioridazinerespiration

-0.142

Valinomycin0.5-10 uM Valinomycinrespiration

0.831

ZnSO42 mM ZnSO4respiration

-0.914

menadione6-10 ug/mL Menadionerespiration

-0.942

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.241

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.928

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.004

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.955

NRP_1Non-replicating persistence stage 1dosRassociated

0.682

Amp0.2mg/mL AmpicillincellWall

0.639

Cephalexin20-100 ug/mL CephalexincellWall

-0.024

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.319

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.576

EMB10-20 ug/mL EthambutolcellWall

1.845

Eta12-40 ug/mL EthionamidecellWall

2.200

INH0.2-0.4 ug/mL IsoniazidcellWall

0.793

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.171

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.134

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.045

BZA0.12 mg/mL BenzamidearomaticAmides

-0.252

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.162

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.926

H2O24 mM hydrogen peroxideDNAdamaging

0.068

Levo10 ug/mL LevofloxacinDNAdamaging

-0.755

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.267

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.146

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.402

UVUV-irradiationDNAdamaging

-1.189

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.924

Antimycin12.5-50 ug/mL Antimycin A?

0.246

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.575

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.611

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.507

PA8240.2-2 ug/mL PA-824?

1.019

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.613

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.274

Verapamil50 uM Verapamil?

0.038

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.380

methoxatin10-20 ug/mL Methoxatin?